Patent · US Active

Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands

US8242281B2 · kind B2 · utility

5Cited by

20References

5Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Ulrich Rosentreter · Binnen, DE
Thomas Kramer · Wuppertal, DE
Andrea Vaupel · Riehen, CH
Walter Hubsch · Wuppertal, DE
Nicole Diedrichs · Wuppertal, DE
Thomas Krahn · Hagen, DE
Klaus Dembowsky · Boston, US
Johannes-Peter Stasch · Wuppertal, DE

Key dates

Filing date	Dec 1, 2006
Grant date	Aug 14, 2012
Priority date	—
Expiry date	Jul 21, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted 2,6-diamino-3,5-dicyano-4-arylpyridines of the formula (I)wherein the definitions of substituent groups R1-R7 are as provided in the specification and claims, to a pharmaceutical composition containing such a compound, to a process for preparation of such materials, and to their use as medicaments for the treatment of cardiovascular disorders and diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.